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OBJECTIVES: The Morisky Medication Adherence Scale (MMAS) has been widely 
used to measure medication adherence; whereas the Adherence to Refills and 
Medications Scale (ARMS) was developed to measure medication adherence 
among elderly population. The objective of the study was to assess medication 
adherence among young adults by using ARMS as well as MMAS and to evaluate 
determine which scales helps better in determining predictors of medication non 
adherence among young adults. METHODS: A cross-sectional survey was 
conducted in a sample of students attending a large university. A validated 
survey instrument was used to obtain information on socio-demographic 
variables, medication behavior, and factors responsible for non-adherence. 
Medication adherence was measured using MMAS (six questions) on a 
dichotomous (yes/no) scale with 'yes' being medically non-adherent and ARMS 
scale with 12 questions on a 4-point Likert scale. Reliability was assessed using 
Cronbach’s alpha. Multiple regression analysis was conducted to assess 
predictors of non-adherence for both the scales. RESULTS: A total of 300 
completed surveys were received (response rate 86%). Mean (SD) age of the 
sample was 23.4 (4.3) years. Participants indicated they were adherent with their 
medication therapy where mean (SD) ARMS score was 1.7 (0.4) (≤2 considered 
adherent) and MMAS scores was 2.6 (1.9) (≤3 considered adherent). Spearman 
correlation coefficient was 0.71 (p<0.0001). Predictors of medication non 
adherence using the ARMS were: forgetfulness (β:0.25, p<0.0001), time constraint 
(β:0.18, p=0.0004), social stigma (β:0.14, p<0.0001), gender (β:-0.09, p=0.01) and 
difficulty in remembering all medications (β:0.09, p=0.0003); whereas that using 
the MMAS were: forgetfulness (β:1.07, p=0.003) and difficulty in remembering all 
medications (β:1.41, p<0.0001). CONCLUSIONS: Medication adherence 
information obtained using ARMS were able to identify more predictors 
compared to MMAS in the cohort of young adults. Future application of the 
scales to different populations could be beneficial.  
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MEDICATION ADHERENCE IN A DIVERSE COHORT OF UNIVERSITY  
STUDENTS  
Kachru N1, Jadav S2, Sansgiry SS2 
1University of Houston, College of Pharmacy, Houston, TX, USA, 2University of Houston, 
Houston, TX, USA  
OBJECTIVES: Research on medication adherence has revealed that majority of 
the adult population encounter problems in compliance with prescribed 
medication. The objectives of this study were to evaluate the extent of 
medication adherence among a diverse cohort of university students and 
determine factors that hamper their adherence to prescribed medications. 
METHODS: A cross-sectional survey was conducted among students attending a 
larger minority designated Tier I University in the state of Texas. The validated 
instrument administered consisted of 41 questions on four domains: socio-
demographic, medication behavior, extent of medication adherence, and reasons 
for non-adherence. Reliability was assessed using Cronbach’s alpha. For extent 
of medication adherence/non-adherence, ‘One Sample T-test’ was conducted 
and for the factors leading to medication non-adherence, multiple regression 
analysis was used. RESULTS: A total of 300 completed survey were obtained 
(response rate 86%). The mean age of sample was 23.39 years (SD: 4.32). The 
sample distribution by ethnicity was Hispanics (32%), Asians (31%) and Whites 
non-hispanic (22%), African American (12%) and other (3%). The overall mean 
medication adherence score was 1.77 (SD: 0.44) (scale 1= never missing a dose to 
4= always missing a dose). Most (73.3%) were identified as "medically adherent" 
(mean medication adherence score ≤ 2). Controlling for all other factors (age, 
race, educational level, current major, insurance status, relationship status, 
current medication, number of medications in last month, chronic conditions 
and social stigma), following were found to be significant predictors that hamper 
medication adherence: forgetfulness (β: 0.2511, p<0.0001), time constraint (β: 
0.1801, p=0.0004), social stigma (β: 0.1416, p<0.0001), gender (β: -0.0907, p=0.0119) 
and difficulty in remembering all medications (β: 0.0917, p=0.0003). 
CONCLUSIONS: Our cohort of young diverse university students was found to be 
medically adherent. However, forgetfulness, time constraint, social stigma, 
gender and difficulty in remembering all medications were found significant in 
hampering their medication adherence.  
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DEFINING CLINICALLY MEANINGFUL CHANGES FOR THE PATIENT PERCEPTION 
OF INTENSITY OF URGENCY SCALE (PPIUS) IN MEN WITH LOWER URINARY 
TRACT SYMPTOMS (LUTS) ASSOCIATED WITH BENIGN PROSTATIC 
HYPERPLASIA (BPH)  
Hakimi Z1, Mathias SD2, Crosby R2, Odeyemi IA3, Nazir J3 
1Astellas Pharma Global Development, Leiden, The Netherlands, 2Health Outcomes Solutions, 
Winter Park, FL, USA, 3Astellas Pharma Europe Ltd, Chertsey, UK  
OBJECTIVES: The PPIUS, previously validated, is a single-item patient-reported 
rating scale that captures degree of urgency associated with micturition and/or 
incontinence. We sought to establish the MID of the PPIUS in patients with lower 
urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia 
(BPH). METHODS: Patients with LUTS associated with BPH enrolled in a Phase III, 
randomized, double-blind, 12-week study of fixed dose combinations of 
solifenacin succinate with tamsulosin hydrochloride Oral Controlled Absorption 
System (OCAS), OCAS monotherapy, and placebo completed the PPIUS prior to 
visits two (baseline), three, four, and five (end of study [EOS]). Three separate 
scores were derived from the PPIUS including the Total Urgency Score (TUS), 
mean number of urgency episodes (PPIUS grade three and four) (MNUE), and 
urgency-incontinence episodes (MNUIE) per 24 hours (for those with >1 
incontinence episode). Two Patient Global Impression (PGI) ratings and a Clinical 
Global Impression (CGI) rating were completed at baseline and EOS. Anchor- and 
distribution-based MID estimates for the PPIUS were calculated. RESULTS: 1,184 
males were enrolled (99% Caucasian; mean age: 65; mean BMI: 28 kg/m2). 
Correlation analyses supported using CGI and PGI ratings at EOS as anchors for 
the TUS and one PGI rating for the MNUE. Correlations were too low to estimate 
the MID for the MNUIE. A 1-unit change in PGI and CGI ratings predicted a 
change of 3.95-5.79 for TUS and 1.86 for MNUE. Distribution-based estimates 
resulted in a minimal detectable change (MDC) of 4.57 for TUS and 1.50 for 
MNUE. After integrating anchor- and distribution-based estimates, the MID 
estimates for TUS were 5.5-6.0 and 1.8-2.0 for MNUE. CONCLUSIONS: MID 
estimates provide guidance for defining clinically meaningful changes, defining 
a clinical responder, and examining cumulative distribution functions. Future 
research should confirm these estimates using patients whose condition 
worsened, and using more relevant anchors for the MNUIE.  
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TRANSLATION AND LINGUISTIC VALIDATION OF THE FACIT-DYSPNEA FOR 
USE WITH PATIENTS EXPERIENCING DYSPNEA WORLDWIDE  
Arnold BJ, Bredle J, Savic L, Parks-Vernizzi E, Dhar J 
FACITtrans, Elmhurst, IL, USA  
OBJECTIVES: Translation of patient reported outcomes (PRO) measures is an 
essential component of the research methodology required when preparing for 
multinational clinical trials. One such measure is the Functional Assessment of 
Chronic Illness Therapy-Dyspnea questionnaire (FACIT-Dyspnea), which 
evaluates the quality of life (QOL) of patients suffering from dyspnea. METHODS: 
This study was designed to linguistically validate the FACIT-Dyspnea scale for 
use in Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, 
Denmark, Hungary, Hong Kong, Ireland, Italy, Mexico, New Zealand, South 
Korea, Poland, Taiwan, and the UK. The combined sample consisted of 130 
patients (62 males/68 females) who were experiencing dyspnea. Patient mean 
age was 58 years, and 118 patients were receiving treatment at the time of 
administration. The sample consisted of patients who speak Chinese, Czech, 
Danish, Dutch, English, French, German, Hungarian, Italian, Korean, Polish, 
Portuguese and Spanish. The FACIT-Dyspnea was translated based on the 
established FACIT methodology. Patients completed the respective translated 
questionnaire and then participated in cognitive interviews to determine if there 
were any problems with the translations or item content. Qualitative analyses 
were performed in order to confirm the validity of the translations. RESULTS: 
During the translation process, some items proved difficult to translate for other 
cultures (e.g. “flights of stairs”, “sweeping and mopping”). Once all issues were 
resolved the FACIT-Dyspnea translations were well understood and relevant to 
patients from a wide range of countries and cultures. Very few items required 
modifications to translations as a result of pilot-testing. CONCLUSIONS: The 
FACIT-Dyspnea demonstrated linguistic validity across all 14 languages. The 
translations are considered acceptable for PRO assessment in international 
research and clinical trials.  
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SAT-Q QUESTIONNAIRE: APPLICATION OF RASCH MEASUREMENT FOR 
SELECTING ITEMS AND IMPROVING THE ASSESSMENT OF PATIENT 
SATISFACTION  
Campillo-Álvarez Á, Rodríguez-Aguilella A, Cuervo J, Castejón N, Rebollo P 
LA-SER Group (LA-SER Outcomes), Oviedo, Spain  
OBJECTIVES: In the last years, the assessment of patient satisfaction has become 
a field of interest for public authorities, researchers, and clinicians due to its 
implications specially, in the management of chronic diseases. To this purpose 
the SAT-Q is a questionnaire for measuring patient satisfaction which has been 
developed and validated from a Classical Test Theory (CTT) approach, resulting 
in a 18 item version. The objective of this research focuses on the application of 
the Rasch model in selecting and testing the most appropriate items for the 
assessment of the satisfaction related to pharmacological treatments. 
METHODS: The sample consisted of a total of 202 patients diagnosed with 
chronic illness who were following a pharmacological regimen for at least one 
year. Data were analyzed using the Rasch Partial Credit Model. Parameter 
estimation, model-fit data and separation statistics were computed and 
compared to CTT validation, in order to select those items with better 
psychometrical properties. RESULTS: Misfiting items were deleted, resulting in a 
10 items version. This short form of the SAT-Q showed good model fit and 
represented an accurate measure of the construct. Infit MNSQ ranged from 0.75 
to 1.51 (SD=0.25) and outfit MNSQ ranged from 0.68 to 2.24 (SD=0.45). Person 
separation index and item reliability were 1.90 and 0.97 respectively. Principal 
Component Analysis (PCA) also distinguished a main component that accounted 
for 54.5% of total variance. Score correlation with CTT validation version was 
0.83. On the other hand, item-person map showed that the test was off-target 
and didn’t cover the wide range of the ability scale. CONCLUSIONS: SAT-Q short 
form version has adequate psychometric properties in terms of goodness-of-fit-
test, reliability and validity. Future research is recommended to improve 
discrimination between different degrees of satisfaction and reducing the ceiling 
effect associated with the satisfaction measures.  
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A LITERATURE REVIEW OF THE VARIANCE IN INTERVAL LENGTH BETWEEN 
ADMINISTRATIONS FOR ASSESSMENT OF TEST RETEST RELIABILITY AND 
EQUIVALENCE OF PRO MEASURES  
Quadri N1, Wild D1, Skerritt B2, Muehlhausen W1, O'Donohoe P3 
1Oxford Outcomes, An ICON plc Company, Oxford, UK, 2Oxford Outcomes, Dublin, Ireland, 3CRF 
Health, London, UK  
OBJECTIVES: There appears to be limited agreement about the appropriate 
length of interval required between two administrations of a PRO in a test-retest 
or equivalence study. The objective of this literature review was to determine 
 V A L U E  I N  H E A L T H  1 6  ( 2 0 1 3 )  A 1 - A 2 9 8  A41 
 
 
what administration intervals are used in the development and validation of 
PROs, as a first step towards ascertaining the most appropriate interval between 
administrations for test-retest and equivalence studies for different measures. 
METHODS: A literature review was conducted using the following search terms: 
test retest reliability, equivalence testing, washout period, and interval on 
Psychinfo since January 2003. 554 abstracts were identified. Thirty-two 
additional abstracts from an equivalence study review paper were included 
resulting in a total of 586 abstracts. All abstracts were reviewed and where 
available the administration interval was extracted and collated. RESULTS: One 
percent of the test retest studies had an interval of one hour or less, 18% had an 
interval of 1 day to 1 week, 25% had an interval of 1weeks to 2 weeks, 21% had an 
interval of 2 weeks to 1 month, 9% had an interval of 1 to 2 month, 13 % had an 
interval of 2 months or over, 13% reported a varied interval. In contrast, 50% of 
the equivalence studies had an administration interval of 1 hour or less, 9% had 
an interval of 1 hour to 1 day, 28% had an interval of 1 day to 1 week, 3% an 
interval of 1 to 2 weeks 10% reported a varied interval within the same study. 
CONCLUSIONS: There is a wide variety of administration intervals used in test-
retest and equivalence studies seen within the literature. Considerations around 
the appropriate administration interval to use should be based on, amongst 
other things, an assessment of the stability of the condition involved and the 
complexity of the PRO.  
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THE NOCTURIA IMPACT DIARY® – A NEW PATIENT REPORTED OUTCOME (PRO) 
INSTRUMENT DEVELOPED IN CLOSE DIALOG WITH THE FDA  
Holm-Larsen T1, Andersson F2, van der Meulen E2, Rosen RC3, Norgaard JP4 
1Pharma Evidence, Farum, Denmark, 2Ferring Pharmaceuticals A/S, Copenhagen, Denmark, 
3New England Research Institute, Watertown, MA, USA, 4Ferring Pharmaceutical A/S, 
Copenhagen, Denmark  
OBJECTIVES: Current questionnaires assessing the impact of nocturia (waking up 
at night one or more times to void), e.g. N-QoL, ICIQ-N or IPSS, do not fulfill the new 
FDA PRO guidelines. We report on the development of a new nocturia impact 
measure. METHODS: The following recommended steps were undertaken: 1) 
Literature review identifying an exhaustive pool of concepts, hereafter 
development of draft diary; 2) Cognitive debriefing test (n=23) confirming 
relevance and importance of items and understandability of phrasing. 
Preliminary Rasch analysis. Modified diary developed and 3) Reliability, validity, 
sensitivity and dimensionality tested in randomized, placebo-controlled trial 
(n=56). RESULTS: Step 1 generated 4 domains including 14 items with 5 response 
options (‘a great deal’ to ‘not at all’). Step 2: Content validity supported 11 items 
and suggested 1 new. Revision into a 12-item diary with 2 domain scores. Step 3: 
Dimensionality: Factor and Rasch analyses clearly indicated uni-dimensionality. 
Construct Validity: Known group validity (<3/≥3 voids): Total score D-13.6 points 
at baseline, p=0.03. Fit to Rasch model at baseline 2 of 3 p= >0.05. Reliability: 
Stability over time=0.91. Internal consistency: Cronbachs alpha=0.9. Sensitivity: 
Cohen’s D=0.73. High variance in response options, slight floor effect. Person 
correlation with number of voids=0.31, p=0.02. Final NI diary: Nocturia Impact 
total score calculated from 11 core items. Global impact question (Q12) analyzed 
separately. CONCLUSIONS: All validity and reliability tests of the Nocturia 
Impact Diary® were highly supportive. The sensitivity was acceptable, especially 
the calculation of Cohen’s D based on pooled analysis. The Nocturia Impact 
Diary® is the first nocturia impact assessment tool developed in close dialog with 
FDA and in accordance with the new PRO guidelines. Consequently, it represents 
a valid new tool within nocturia and should be used in conjunction with voiding 
diaries in cross sectional assessments of patient burden or in assessments of 
changes due to treatment of nocturia.  
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USING QUESTIONNAIRE DESIGN TO EXPLORE REPORTING DIFFERENCES FOR 
SPASTICITY RELATED PAIN IN CHILDREN AND ADOLESCENTS WITH CEREBRAL 
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1Health Research Associates, Inc., Seattle, WA, USA, 2Merz Pharmaceuticals GmbH, Frankfurt, 
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OBJECTIVES: To utilize a specific approach in questionnaire design (general to 
specific items) to identify evidences of existing (but initially denied) spasticity-
related pain (SRP) in children with Cerebral Palsy (CP). METHODS: Children and 
adolescents with CP and SRP and their parent/caregivers participated in 
qualitative interviews to evaluate the Questionnaire on Pain Caused by Spasticity 
(QPS), a newly developed Patient Reported and Observer Reported Outcome 
measure that assesses SRP. Interviews were audio recorded and transcribed. 
Child/adolescent questionnaires were compared with the one from their 
corresponding parent/caregiver’s to identify differences in answers provided for 
presence of SRP. Questions first asked about SRP in general, and then in specific 
activity situations (at rest, during usual daily activities, during active 
mobilization, and during physically difficult activities). RESULTS: Eight children 
and adolescents (7-16 years) who participated with their parent/caregivers were 
used for this evaluation. Clinicians confirmed at enrollment that all subjects had 
SRP weekly to daily. Four of the 8 participants reported having no pain on the 
initial general SRP item, yet proceeded to describe their pain in subsequent items 
that asked about severity of pain in specific activity situations. Parent/caregiver 
responses indicated observation of signs of their child’s pain on both the general 
item and the various activity situations. CONCLUSIONS: Because earlier 
qualitative interview data documented instances where children and 
adolescents reported intentionally hiding their pain from their parent/caregivers, 
there is a concern that self-reported pain data may not be trustworthy in this 
population. However, these findings suggest that combining a self-reported and 
an observer-reported assessment produces complimentary results that facilitate 
more accurate measurement of SRP. Results also suggest that in the assessment 
of chronic conditions, structuring child/adolescent questionnaires to make 
multiple (general to descriptive) inquiries of the same concept might facilitate 
discovery of symptoms being initially denied.  
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DETERMINING SUBJECT PREFERENCE FOR ITEMS USING IDIOMATIC OR LITERAL 
PHRASING IN PATIENT QUESTIONNAIRES  
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OBJECTIVES: To review both idiomatic items and items with literal phrasing 
within Patient Reported Outcomes instruments in order to assess subject 
comprehension and preference. Idiomatic items commonly appear in 
psychological questionnaires and clinical outcomes assessments, and frequently 
require translation for use in multinational clinical trials. Though it is theorized 
that idiomatic items will be more comprehensible to lay audiences, previous 
research has shown that they require more rounds of revision during linguistic 
validation in order to achieve conceptual equivalence. METHODS: A patient 
questionnaire containing six idiomatic items underwent linguistic validation in 
six languages. For each item, a literal equivalent was developed and translated. 
During cognitive debriefing, a sample of 147 subjects was presented with both 
idiomatic and literal versions of the six items. Subjects were asked to comment 
on comprehensibility and preference. A control group of 7 subjects was asked for 
feedback on these items in U.S. English. RESULTS: Cognitive debriefing data 
showed preference for the literal item 59% of the time, and for the idiomatic item 
37% of the time. Subjects made no decision 4% of the time. No correlation was 
found between years of education and preference. Only 2 instances of 
comprehension issues occurred, both with the idiomatic items. Literal items 
yielded no comprehension issues. In some languages, an idiomatic equivalent 
was unavailable; these items were omitted from the analysis. Subjects in the 
English-U.S. control group preferred the literal item 74% of the time. 
CONCLUSIONS: In previous research, idiomatic items were shown to require one 
to two more rounds of revision than literal items during translation. Given that 
literal items were understood by all sample members with less than 12 years of 
education, and were preferred by a majority, avoidance of idiomatic items in 
patient questionnaires is recommended.  
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VALIDATION AND PSYCHOMETRIC EVALUATION OF A PATIENT-REPORTED 
ASSESSMENT OF DISEASE BURDEN: EVIDENCE FROM A SAMPLE OF ADULTS 
WITH DIABETES, DEPRESSION, AND RHEUMATOID ARTHRITIS  
McCarrier KP1, Bushnell DM1, Scanlon M1, Nelson DR2, Martin ML1, Buesching DP2 
1Health Research Associates, Inc., Seattle, WA, USA, 2Eli Lilly and Company, Inc., Indianapolis, 
IN, USA  
OBJECTIVES: The Disease Burden Scale (DBS), a 4-item instrument derived from 
the Diabetes Burden Scale (Kaplan 2010), measures the impact of specific health 
conditions on a patient’s overall health, social activities, lifestyle and finances. 
We sought to build on prior validation of the parent instrument by evaluating 
the validity and reproducibility of the DBS and testing equivalence between 
paper and electronic administration modes. METHODS: Adult patients with 
depression, type 2 diabetes, or rheumatoid arthritis were recruited through web-
based advertisements in 8 U.S. cities and completed the DBS on both paper and 
computerized format in a randomized crossover design. A one-week retest was 
also completed. Reproducibility and mode equivalence were assessed using the 
intraclass correlation coefficient (ICC). Cronbach’s alpha was calculated to assess 
internal consistency. To assess convergent validity, the correlation of the DBS to 
the WHO Quality of Life Scale (WHOQOL-BREF) was calculated. ANOVA was used 
to compare mean DBS scores among known groups defined by the MOS-36 MCS 
and PCS subscales. RESULTS: Of the 230 participants that completed baseline 
assessment, 228 (99.1%) completed the one-week retest. The mean age of 
participants was 44.3 years, 51.3% were female, and 58.3% were Caucasian. A 
small amount (n=9; 3.9%) reported their health as Poor. The mean paper DBS 
score was 44.8 (±26.6), and the ICC between paper and computerized 
administration was 0.876. The ICC for the one-week retest of the paper format 
was 0.944, and the DBS was found to be internally consistent (Cronbach’s 
alpha=0.899). Significant correlations were found with the WHOQOL-BREF 
(r=0.460 to 0.646; p<0.01) and the instrument discriminated between 
hypothesized MOS-36 score groups (MCS, p<0.01; PCS, p<0.01). CONCLUSIONS: 
The DBS was observed to be reproducible and internally consistent, 
demonstrated appropriate convergent validity, and significantly discriminated 
between levels of overall health status. Equivalence between paper and web-
based administration was demonstrated.  
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VALIDITY OF ANKYLOSING SPONDYLITIS PATIENT-REPORTED OUTCOME 
INSTRUMENTS IN THE GENERAL AXIAL SPONDYLOARTHRITIS POPULATION  
van Tubergen A1, Black P2, McKenna S3, Coteur G4 
1Maastricht University Medical Center, Maastricht, The Netherlands, 2ERT, Philadelphia, PA, 
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OBJECTIVES: Axial spondyloarthritis (axSpA) includes both ankylosing 
spondylitis (AS) and non-radiographic axSpA (nr-axSpA, axSpA with no 
definitive sacroiliitis on X-ray). Several patient-reported outcome (PRO) 
instruments have been validated in AS. This study evaluated the content 
validity, and assessed the psychometric measurement properties, of such PROs 
in the broad axSpA population. METHODS: PROs assessed: Total and Nocturnal 
Spinal Pain Numerical Rating Scales, PtGA, BASDAI (including fatigue and 
